Artykuły w czasopismach na temat „Oncogenic transformations”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Oncogenic transformations”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Paterno, G. D., L. L. Gillespie, M. S. Dixon, J. M. Slack i J. K. Heath. "Mesoderm-inducing properties of INT-2 and kFGF: two oncogene-encoded growth factors related to FGF". Development 106, nr 1 (1.05.1989): 79–83. http://dx.doi.org/10.1242/dev.106.1.79.
Pełny tekst źródłaIto, Reina E., Chitose Oneyama i Kazuhiro Aoki. "Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction". PLOS ONE 16, nr 4 (1.04.2021): e0249388. http://dx.doi.org/10.1371/journal.pone.0249388.
Pełny tekst źródłaCalabrese, Fiorella, Federica Pezzuto, Francesca Lunardi, Francesco Fortarezza, Sofia-Eleni Tzorakoleftheraki, Maria Vittoria Resi, Mariaenrica Tiné, Giulia Pasello i Paul Hofman. "Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer". International Journal of Molecular Sciences 23, nr 8 (9.04.2022): 4164. http://dx.doi.org/10.3390/ijms23084164.
Pełny tekst źródłaClark, SS, Y. Liang, CK Reedstrom i SQ Wu. "Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes". Blood 84, nr 12 (15.12.1994): 4301–9. http://dx.doi.org/10.1182/blood.v84.12.4301.bloodjournal84124301.
Pełny tekst źródłaAlkharam, A. S., i D. E. Watt. "Risk Scaling Factors from Inactivation to Chromosome Aberrations, Mutations and Oncogenic Transformations in Mammalian Cells". Radiation Protection Dosimetry 70, nr 1 (1.04.1997): 537–40. http://dx.doi.org/10.1093/oxfordjournals.rpd.a032012.
Pełny tekst źródłaJulien, Sylvie, Mirjana Radosavljevic, Nathalie Labouret, Sophie Camilleri-Broet, Frederic Davi, Martine Raphael, Thierry Martin i Jean-Louis Pasquali. "AIDS Primary Central Nervous System Lymphoma: Molecular Analysis of the Expressed VH Genes and Possible Implications for Lymphomagenesis". Journal of Immunology 162, nr 3 (1.02.1999): 1551–58. http://dx.doi.org/10.4049/jimmunol.162.3.1551.
Pełny tekst źródłade Oliveira, Guilherme A. P., Elaine C. Petronilho, Murilo M. Pedrote, Mayra A. Marques, Tuane C. R. G. Vieira, Elio A. Cino i Jerson L. Silva. "The Status of p53 Oligomeric and Aggregation States in Cancer". Biomolecules 10, nr 4 (4.04.2020): 548. http://dx.doi.org/10.3390/biom10040548.
Pełny tekst źródłaNeitzel, Carina, Philipp Demuth, Simon Wittmann i Jörg Fahrer. "Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities". Cancers 12, nr 7 (29.06.2020): 1731. http://dx.doi.org/10.3390/cancers12071731.
Pełny tekst źródłaShrivastava, Richa, i Smrati Bhadauria. "Role of Growth Factor Signaling in Cancer". Defence Life Science Journal 1, nr 1 (1.06.2016): 34. http://dx.doi.org/10.14429/dlsj.1.10059.
Pełny tekst źródłaAggarwal, Vaishali, Hardeep Singh Tuli, Jagjit Kaur, Diwakar Aggarwal, Gaurav Parashar, Nidarshana Chaturvedi Parashar, Samruddhi Kulkarni i in. "Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells". Biomedicines 8, nr 5 (30.04.2020): 103. http://dx.doi.org/10.3390/biomedicines8050103.
Pełny tekst źródłaMalumbres, Marcos, Ignacio Pérez De Castro, María I. Hernández, María Jiménez, Teresa Corral i Angel Pellicer. "Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b". Molecular and Cellular Biology 20, nr 8 (15.04.2000): 2915–25. http://dx.doi.org/10.1128/mcb.20.8.2915-2925.2000.
Pełny tekst źródłaNgalim, Siti Hawa, Astrid Magenau, Guillaume Le Saux, J. Justin Gooding i Katharina Gaus. "How Do Cells Make Decisions: Engineering Micro- and Nanoenvironments for Cell Migration". Journal of Oncology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/363106.
Pełny tekst źródłaNishizawa, Toshihiro, i Hidekazu Suzuki. "Gastric Carcinogenesis and Underlying Molecular Mechanisms:Helicobacter pyloriand Novel Targeted Therapy". BioMed Research International 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/794378.
Pełny tekst źródłaPodstawski, Przemysław, Marcin Samiec, Maria Skrzyszowska, Tomasz Szmatoła, Ewelina Semik-Gurgul i Katarzyna Ropka-Molik. "The Induced Expression of BPV E4 Gene in Equine Adult Dermal Fibroblast Cells as a Potential Model of Skin Sarcoid-like Neoplasia". International Journal of Molecular Sciences 23, nr 4 (10.02.2022): 1970. http://dx.doi.org/10.3390/ijms23041970.
Pełny tekst źródłaHsieh, James J., Shugaku Takeda, David Y. Chen, Todd D. Westergard, Jill K. Fisher, Jeffrey A. Rubens, Satoru Sasagawa, Jason T. Kan, Stanley J. Korsmeyer i Emily H. Cheng. "Proteolysis of MLL Family Proteins Is Essential for Taspase1−Orchestrated Cell Cycle Progression." Blood 108, nr 11 (16.11.2006): 769. http://dx.doi.org/10.1182/blood.v108.11.769.769.
Pełny tekst źródłaSankar, Savita, Jason M. Tanner, Russell Bell, Aashi Chaturvedi, R. Lor Randall, Mary C. Beckerle i Stephen L. Lessnick. "A Novel Role for Keratin 17 in Coordinating Oncogenic Transformation and Cellular Adhesion in Ewing Sarcoma". Molecular and Cellular Biology 33, nr 22 (16.09.2013): 4448–60. http://dx.doi.org/10.1128/mcb.00241-13.
Pełny tekst źródłaFarhana, Aisha, Avin Ee-Hwan Koh, Sangeetha Kothandan, Abdullah Alsrhani, Pooi Ling Mok i Suresh Kumar Subbiah. "Treatment of HT29 Human Colorectal Cancer Cell Line with Nanocarrier-Encapsulated Camptothecin Reveals Histone Modifier Genes in the Wnt Signaling Pathway as Important Molecular Cues for Colon Cancer Targeting". International Journal of Molecular Sciences 22, nr 22 (13.11.2021): 12286. http://dx.doi.org/10.3390/ijms222212286.
Pełny tekst źródłaGiamougiannis, Panagiotis, Pierre L. Martin-Hirsch i Francis L. Martin. "The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia". Carcinogenesis 42, nr 3 (20.02.2021): 327–43. http://dx.doi.org/10.1093/carcin/bgab010.
Pełny tekst źródłaBorzillo, G. V., i C. J. Sherr. "Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures". Molecular and Cellular Biology 9, nr 9 (wrzesień 1989): 3973–81. http://dx.doi.org/10.1128/mcb.9.9.3973-3981.1989.
Pełny tekst źródłaBorzillo, G. V., i C. J. Sherr. "Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures." Molecular and Cellular Biology 9, nr 9 (wrzesień 1989): 3973–81. http://dx.doi.org/10.1128/mcb.9.9.3973.
Pełny tekst źródłaLiu, Yingting, Jeremy Purvis, Andrew Shih, Joshua Weinstein, Neeraj Agrawal i Ravi Radhakrishnan. "A Multiscale Computational Approach to Dissect Early Events in the Erb Family Receptor Mediated Activation, Differential Signaling, and Relevance to Oncogenic Transformations". Annals of Biomedical Engineering 35, nr 6 (2.02.2007): 1012–25. http://dx.doi.org/10.1007/s10439-006-9251-0.
Pełny tekst źródłaFarhana, Aisha, Avin Ee-Hwan Koh, Jia Bei Tong, Abdullah Alsrhani, Suresh Kumar Subbiah i Pooi Ling Mok. "Nanoparticle-Encapsulated Camptothecin: Epigenetic Modulation in DNA Repair Mechanisms in Colon Cancer Cells". Molecules 26, nr 17 (6.09.2021): 5414. http://dx.doi.org/10.3390/molecules26175414.
Pełny tekst źródłaBitler, Benjamin G., Lauren S. Fink, Zhi Wei, Jeffrey R. Peterson i Rugang Zhang. "A High-Content Screening Assay for Small-Molecule Modulators of Oncogene-Induced Senescence". Journal of Biomolecular Screening 18, nr 9 (3.06.2013): 1054–61. http://dx.doi.org/10.1177/1087057113491827.
Pełny tekst źródłaHarrington, M. A., F. Gonzales i P. A. Jones. "Effect of cellular determination on oncogenic transformation by chemicals and oncogenes". Molecular and Cellular Biology 8, nr 10 (październik 1988): 4322–27. http://dx.doi.org/10.1128/mcb.8.10.4322-4327.1988.
Pełny tekst źródłaHarrington, M. A., F. Gonzales i P. A. Jones. "Effect of cellular determination on oncogenic transformation by chemicals and oncogenes." Molecular and Cellular Biology 8, nr 10 (październik 1988): 4322–27. http://dx.doi.org/10.1128/mcb.8.10.4322.
Pełny tekst źródłaXu, Shihao, Cody M. Spencer i Joshua Munger. "Transformation with Oncogenic Ras and the Simian Virus 40 T Antigens Induces Caspase-Dependent Sensitivity to Fatty Acid Biosynthetic Inhibition". Journal of Virology 89, nr 12 (8.04.2015): 6406–17. http://dx.doi.org/10.1128/jvi.03671-14.
Pełny tekst źródłaXu, Mai, Qing Yu, Ramesh Subrahmanyam, Michael J. Difilippantonio, Thomas Ried i Jyoti Misra Sen. "β-Catenin Expression Results in p53-Independent DNA Damage and Oncogene-Induced Senescence in Prelymphomagenic Thymocytes In Vivo". Molecular and Cellular Biology 28, nr 5 (26.12.2007): 1713–23. http://dx.doi.org/10.1128/mcb.01360-07.
Pełny tekst źródłaMaeda, Takahiro, Robin Hobbs, Taha Merghoub, Ilhem Guernah, Arthur Zelent, Julie Teruya-Feldstein i Pier Paolo Pandolfi. "POKEMON Is a Proto-Oncogene Which Plays a Key Role in Lymphomagenesis." Blood 104, nr 11 (16.11.2004): 3489. http://dx.doi.org/10.1182/blood.v104.11.3489.3489.
Pełny tekst źródłaLand, H., A. C. Chen, J. P. Morgenstern, L. F. Parada i R. A. Weinberg. "Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts". Molecular and Cellular Biology 6, nr 6 (czerwiec 1986): 1917–25. http://dx.doi.org/10.1128/mcb.6.6.1917-1925.1986.
Pełny tekst źródłaLand, H., A. C. Chen, J. P. Morgenstern, L. F. Parada i R. A. Weinberg. "Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts." Molecular and Cellular Biology 6, nr 6 (czerwiec 1986): 1917–25. http://dx.doi.org/10.1128/mcb.6.6.1917.
Pełny tekst źródłaLy, Tony, Aki Endo, Alejandro Brenes, Marek Gierlinski, Vackar Afzal, Andrea Pawellek i Angus I. Lamond. "Proteome-wide analysis of protein abundance and turnover remodelling during oncogenic transformation of human breast epithelial cells". Wellcome Open Research 3 (2.05.2018): 51. http://dx.doi.org/10.12688/wellcomeopenres.14392.1.
Pełny tekst źródłaSasaki, Rumi, Mako Narisawa-Saito, Takashi Yugawa, Masatoshi Fujita, Hironori Tashiro, Hidetaka Katabuchi i Tohru Kiyono. "Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes". Carcinogenesis 30, nr 3 (6.01.2009): 423–31. http://dx.doi.org/10.1093/carcin/bgp007.
Pełny tekst źródłaChan, Lai N., Christian Hurtz, Huimin Geng, Franziska Auer, Zhengshan Chen, Gang Xiao, Jae-Woong Lee, Kadriye Nehir Cosgun, B. Hilda Ye i Markus Muschen. "Ras-Driven B-Cell Transformation Targets Developmental Rewiring of Cytokine to Pre-B Cell Receptor Signaling". Blood 132, Supplement 1 (29.11.2018): 1336. http://dx.doi.org/10.1182/blood-2018-99-115514.
Pełny tekst źródłaGarcía-Silva, Susana, i Ana Aranda. "The Thyroid Hormone Receptor Is a Suppressor of ras-Mediated Transcription, Proliferation, and Transformation". Molecular and Cellular Biology 24, nr 17 (1.09.2004): 7514–23. http://dx.doi.org/10.1128/mcb.24.17.7514-7523.2004.
Pełny tekst źródłaDe, Pradip, Brett James Rozeboom, Jennifer Carlson Aske i Nandini Dey. "Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors". Cancers 12, nr 6 (11.06.2020): 1541. http://dx.doi.org/10.3390/cancers12061541.
Pełny tekst źródłaNtziachristos, Panagiotis, Kelly Arcipowski, Carlos Alberto Martinez, Yixing Zhu, Andrew G. Volk, Suresh Kumar, Paul M. Thomas i in. "Therapeutic Targeting of the Histone Ubiquitination-Methylation Axis in T Cell Leukemia". Blood 128, nr 22 (2.12.2016): 1532. http://dx.doi.org/10.1182/blood.v128.22.1532.1532.
Pełny tekst źródłaAlghisi, Elisa, Michele Malagola, Cristina Santoriello, Cristina Skert, Carla Filì, Cesare Bergonzi, Annalisa Peli i in. "Establishing a New Zebrafish Model to Study Malignant Transformation in Myeloproliferative Disorders". Blood 118, nr 21 (18.11.2011): 4711. http://dx.doi.org/10.1182/blood.v118.21.4711.4711.
Pełny tekst źródłaGuo, Beichu, i Jinyu Zhang. "Senescence associated inflammasome (SAI) activation promotes cancer progression (TUM4P.909)". Journal of Immunology 192, nr 1_Supplement (1.05.2014): 138.10. http://dx.doi.org/10.4049/jimmunol.192.supp.138.10.
Pełny tekst źródłaMali, Raghuveer Singh, Peilin Ma, Li-Fan Zeng, Holly Martin, Baskar Ramdas, Yantao He, Emily Sims i in. "Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT". Blood 120, nr 13 (27.09.2012): 2669–78. http://dx.doi.org/10.1182/blood-2011-08-375873.
Pełny tekst źródłaKannan, Perry, i Michael A. Tainsky. "Coactivator PC4 Mediates AP-2 Transcriptional Activity and Suppresses ras-Induced Transformation Dependent on AP-2 Transcriptional Interference". Molecular and Cellular Biology 19, nr 1 (1.01.1999): 899–908. http://dx.doi.org/10.1128/mcb.19.1.899.
Pełny tekst źródłaBose, Indrani. "Tipping the Balance: A Criticality Perspective". Entropy 24, nr 3 (14.03.2022): 405. http://dx.doi.org/10.3390/e24030405.
Pełny tekst źródłaLadenson, P. W. "Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer". Clinical Chemistry 42, nr 1 (1.01.1996): 183–87. http://dx.doi.org/10.1093/clinchem/42.1.183.
Pełny tekst źródłaSanchez-Martin, Marta, i Adolfo Ferrando. "The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia". Blood 129, nr 9 (2.03.2017): 1124–33. http://dx.doi.org/10.1182/blood-2016-09-692582.
Pełny tekst źródłaLim, Jonathan K. M., Alberto Delaidelli, Sean W. Minaker, Hai-Feng Zhang, Milena Colovic, Hua Yang, Gian Luca Negri i in. "Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance". Proceedings of the National Academy of Sciences 116, nr 19 (18.04.2019): 9433–42. http://dx.doi.org/10.1073/pnas.1821323116.
Pełny tekst źródłaAlema, S., F. Tato i D. Boettiger. "myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts". Molecular and Cellular Biology 5, nr 3 (marzec 1985): 538–44. http://dx.doi.org/10.1128/mcb.5.3.538-544.1985.
Pełny tekst źródłaAlema, S., F. Tato i D. Boettiger. "myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts." Molecular and Cellular Biology 5, nr 3 (marzec 1985): 538–44. http://dx.doi.org/10.1128/mcb.5.3.538.
Pełny tekst źródłaSeyedmehdi, Shojaee, Zhengshan Chen, Maike Buchner, Christian Hurtz, Huimin Geng, Hilde Schjerven, Lai N. Chan i in. "Erk and Stat5 Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia". Blood 124, nr 21 (6.12.2014): 787. http://dx.doi.org/10.1182/blood.v124.21.787.787.
Pełny tekst źródłaMumby, M. C., i G. Walter. "Protein phosphatases and DNA tumor viruses: transformation through the back door?" Cell Regulation 2, nr 8 (sierpień 1991): 589–98. http://dx.doi.org/10.1091/mbc.2.8.589.
Pełny tekst źródłaSulis, Maria Luisa, Teresa Palomero, Pedro J. Real, Kelly C. Barnes, Peter Aplan, Neal Copeland, Dave Utpal i in. "Identification of Oncogenic Pathways of T-Acute Lymphoblastic Leukemia (T-ALL) through Gene Expression Profiling of Mouse Tumor Models." Blood 108, nr 11 (1.11.2006): 2234. http://dx.doi.org/10.1182/blood.v108.11.2234.2234.
Pełny tekst źródłaPandya, Jyotsna, i Dennis M. Walling. "Oncogenic Activity of Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Is Down-Regulated by Lytic LMP-1". Journal of Virology 80, nr 16 (15.08.2006): 8038–46. http://dx.doi.org/10.1128/jvi.00180-06.
Pełny tekst źródła